April 17, 2015

Generic Pharmaceutical Association branches out with the creation of the Biosimilars Council. 

April 14, 2015

DSN editor in chief Rob Eder talks about why Congress needs to rethink current DEA regulations that block access to medications to chronic pain patients.

 

April 7, 2015

The Canadian Generic Pharmaceutical Association on Tuesday established a new Biosimilars Board. 

 

 

April 1, 2015

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

March 17, 2015

A new Harris Poll reveals some surprise findings on Americans' preference for generic or branded drugs.

March 16, 2015

The letter to the editor emphasized the need for a comprehensive approach to curbing prescription drug abuse and diversion.

March 13, 2015

How do the nation’s pharmacists rate with Americans? According to Gallup, the answer is very, very high year after year.

March 12, 2015

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

March 6, 2015

The Food and Drug Administration approved Zarxio, making it the first approved biosimilar product in the United States.

March 5, 2015

CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 19, 2015

IRI and Kline & Co. establish an exclusive alliance to provide clients with a greater level of actionable insights.

February 10, 2015

China Jo-Jo Drugstores entered into a service agreement with Alibaba Health Information Technology to utilize its electronic prescription platform. 

February 9, 2015

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

February 6, 2015

The pharma industry praised outgoing Food and Drug Administration commissioner Margaret Hamburg and welcomed Stephen Ostroff, who will assume the role of acting commissioner.

February 6, 2015

Prestige Brands will be resuming healthcare professional marketing programs in support of its Monistat vaginal treatments.

February 5, 2015

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

February 4, 2015

DSN examines chain pharmacy, including in-depth coverage of telehealth, generic drug prices, and the GPhA CEO to step down, as well as Uhl appointed director of OGD, in this multi-page report.

February 2, 2015

A proposal in the Budget of the U.S. government, fiscal year 2016 calls for an increase in retail pharmacy prescription drug co-pays.

January 29, 2015

Rite Aid reported a 4.8% increase in same-store sales benefiting in part from a strong flu season to date.

 

January 27, 2015

Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to Tuesday’s hearing titled, “Examining Public Health Legislation to Help Patients and Local Communities.”

January 21, 2015

Eisai on Tuesday announced the launch of a new savings card for Belviq (lorcaserin HCl) CIV, the most-prescribed branded FDA-approved prescription drug therapy for chronic weight management.